Filer Snapshot

Stonepine Capital Management, LLC

CIK 0001440771. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

80

Latest filing

16 Jun 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: 13F-HR for Q1 2026. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Open 13F portfolio Save page

Latest 13F portfolio

$113.69M

66 holdings for Q1 2026

Open portfolio

Largest parsed holding

VSTM

$17.5M reported value

Open holding

13D/G large stake

Eloxx Pharmaceuticals, Inc.

09 Jun 2026 · 9.9% ownership

Open 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it
Source: SEC Schedule 13D/G

SCHEDULE 13G filed on 16 Jun 2026 for CIK 0001440771.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

13F portfolio$113.69M

Quarterly institutional holdings reported on Form 13F; not total AUM.

Forms 3/4/5 positions$47.2M

Reporting-owner positions with enough filing detail to estimate value.

Latest reported 13F value

13F
$113.69M

Reported market value from the latest parsed Form 13F information table; this is not total assets under management.

Source: SEC Form 13FScope: U.S.-listed equity holdings

Forms 3/4/5 position value

3/4/5
$47.2M

Estimated from parsed Forms 3/4/5 when filings include enough share and price data.

Source: Forms 3/4/5Confidence: Estimated when price data is available

Largest 13F holdings

13F
VSTM TENX EOLS ADMA CAMP
+15 moreNKTR ZVRA CRBP ABEO KZIA ANTX SLGL XOMA AYTU CRIS TELA IKT CBIO ACET XFOR

Largest symbols in the latest parsed Form 13F information table.

Freshness: Latest parsed 13F period

Largest linked holdings

Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.

QNRX

Largest 13F holdings

Largest symbols in the latest parsed Form 13F information table.

VSTM TENX EOLS ADMA CAMP NKTR ZVRA CRBP
+12 moreABEO KZIA ANTX SLGL XOMA AYTU CRIS TELA IKT CBIO ACET XFOR

Largest active 13G stakes

Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.

QNRX VSTM TENX OPTN SRZN CRIS
+12 moreINO TELA INAB AYTU EDSA KZR SINT CALC APRE CNSP Eloxx Pharmaceuticals, Inc. CLRB
How to read these SEC ownership signals
  • Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
  • Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
  • Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
2900 Nw Clearwater Drive, Suite 100 11, Bend, OR, 97703
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 2 profile fields available
Incorporated in
DE
Fiscal year end
31 December

Filer intelligence

What SEC filings say about Stonepine Capital Management, LLC

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Open 13F portfolio Save filer

Quick read

  • Latest parsed 13F shows $113.69M across 66 reported holdings for Q1 2026.
  • Largest parsed 13F holding: VSTM at $17.5M.
  • 5 recent 13D/G stake rows found; top row is Eloxx Pharmaceuticals, Inc. at 9.9% ownership.
  • Forms 3/4/5 show insider context for QNRX worth $47.2M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio 66 rows

Quarterly institutional portfolio holdings.

Open
13D/G stakes 5 rows

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 2 rows

Officer, director, and 10% owner holdings or transactions.

Open

Top parsed 13F holdings

Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.

Q1 2026 - 14 May 2026

Top 5 concentration

47%

Share of latest parsed 13F value represented by the visible holdings below.

Top 5 reported value

$53.12M

Compared with $113.69M total 13F value.

Top 5 net change

+$24.07M

Position-value change inside the visible top holdings only.

13F concentration map

A simple visual split of the latest parsed 13F portfolio.

Largest add: TENX · Largest trim: INDV

VSTM TENX EOLS ADMA CAMP Other holdings

VSTM

15.4%

Verastem Inc

$17.5M

TENX

13.7%

Tenax Therapeutics Inc

$15.59M

EOLS

6.4%

Evolus Inc

$7.23M

ADMA

5.9%

Adma Biologics Inc

$6.67M

CAMP

5.4%

Camp4 Therapeutics Corp

$6.13M

13D/G large-stake context

Eloxx Pharmaceuticals, Inc.

09 Jun 2026 · Common Stock

9.9%
Issuer page 13D/G history

SINT

02 Jun 2026 · Common Stock

9.9%
Issuer page 13D/G history

CLRB

04 May 2026 · Common Stock

9.9%
Issuer page 13D/G history

CNSP

31 Mar 2026 · Common Stock

9.9%
Issuer page 13D/G history

Forms 3/4/5 insider context

QNRX

26 Mar 2026 · 10% owner

$47.2M
Issuer page Owner page

CHMA

06 May 2021 · 10% owner

Issuer page Owner page

Latest update

What changed recently for Stonepine Capital Management, LLC

New filing available

Latest Schedule 13D/G period: 09 Jun 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

16 Jun 2026

Page type

Filer profile

Latest period

09 Jun 2026

Schedule 13D/G context is visible from filings filed on 16 Jun 2026.

Open filer profile Browse recent public updates

Benchmark Context

Benchmark context for this company

Stonepine Capital Management, LLC has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest Schedule 13D/G period: 09 Jun 2026. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

SEC filing record

CIK 0001440771 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
80
First seen
11 Feb 2016
Latest filing
16 Jun 2026
Entity
Company

Observed form types

13F-HR 13F-HR/A 3 SCHEDULE 13G SCHEDULE 13G/A

CIK-linked evidence first

Stonepine Capital Management, LLC SEC filings Stonepine Capital Management, LLC 13F portfolio Stonepine Capital Management, LLC 13D/G history Stonepine Capital Management, LLC owner filings Open SEC filing index

Latest Filings

Showing the latest 12 of 80 SEC filings for Stonepine Capital Management, LLC.

Open full filing history
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
16 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
09 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 May 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
11 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
27 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .